Via Francis Medical
“Like most companies, Francis Medical is facing several unique challenges brought on by the coronavirus pandemic. However, unlike many companies facing the prospect of lost revenues, the real enemy of a pre-revenue startup company, like Francis Medical, is lost time. ‘Every day of delay to our timeline could mean one day later to market,’ says Francis Medical CEO, Mike Kujak. He adds, ‘It is imperative to our investors, employees, and the millions of men in need of this therapy, that we continue to make as much progress as possible during these challenging times.’”
“Of particular challenge to Francis Medical is that when the pandemic hit, we were in the initial stages of kicking off our US feasibility study. This study was on the heels of finishing, in early March, the last of a series of 14 patients successfully treated in Panama. The Panama study tested our unique water vapor ablation technology for the treatment of prostate cancer and was designed to mimic the hemi-ablation procedure planned for the US study. ‘Our results in Panama were extremely encouraging and we are all very excited to get the US study going,’ says Francis Medical founder and Chief Technology Officer, Michael Hoey.”
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.
